“Psychedelic drug maker mentioned for significant stock price increase.”

“Biotechnology company focused on psychedelic medicine and FDA approval for COMP360.”

“Biotechnology company focused on psychedelic medicine and treatment-resistant depression.”

“Developing COMP360 psilocybin for treatment-resistant depression, engaging with the FDA, completing clinical trials, and planning a commercial launch.”

“Biotech company developing psilocybin-based treatments for depression.”